Entrar/Registro  
INICIO ENGLISH
 
Revista Médica del Instituto Mexicano del Seguro Social
   
MENÚ

Contenido por año, Vol. y Num.

Índice de este artículo

Información General

Instrucciones para Autores

Mensajes al Editor

Directorio






>Revistas >Revista Médica del Instituto Mexicano del Seguro Social >Año 2018, No. S1


García-González AI, Axtle-Serrano Z, López-Teros M, Szlejf C, Martínez-Ruiz A, Rosas-Carrasco O
Intervenciones clínicas en obesidad osteosarcopénica: alimentación, actividad física y psicológica
Rev Med Inst Mex Seguro Soc 2018; 56 (S1)

Idioma: Español
Referencias bibliográficas: 35
Paginas: 82-93
Archivo PDF: 319.18 Kb.


Texto completo




RESUMEN

La obesidad osteosarcopénica (OOS) es una condición que representa diversos desenlaces adversos en el adulto mayor. Al ser una condición que incluye tres tejidos (obesidad, sarcopenia y osteopenia/osteoporosis), se requiere de intervenciones clínicas simultáneas y multidisciplinarias para lograr revertirla. Hasta el momento, han sido publicados artículos de revisión enfocados solo a la nutrición y a la actividad física. Sin embargo, consideramos que es necesario reunir la evidencia del nivel nutricional (en cuanto a microy macronutrientes), de la actividad física habitual o personalizada, de los potenciales tratamientos farmacológicos para la sarcopenia, del actual tratamiento farmacológico para la osteopenia/osteoporosis y, por último, en torno a las posibles intervenciones psicológicas enfocadas a tratar la comorbilidad psiquiátrica (ansiedad o depresión) y directamente hacia la mejora de la composición corporal en adultos mayores.


Palabras clave: Ejercicio físico, Sarcopenia, Obesidad, Anciano frágil.


REFERENCIAS

  1. Szlejf C, Parra-Rodriguez L, Rosas-Carrasco O. Osteosarcopenic Obesity: Prevalence and Relation With Frailty and Physical Performance in Middle- Aged and Older Women. J Am Med Dir Assoc. 2017 Aug 1;18(8): 733.e1-733.e5.

  2. Kelly OJ, Gilman JC, Kim Y, Ilich JZ. Macronutrient intake and distribution in the etiology, prevention and treatment of osteosarcopenic obesity. Curr Aging Sci. 2017;10(2):83-105.

  3. Volpato S, Bianchi L, Cherubini A, Landi F, Maggio M, Savino E, et al. Prevalence and Clinical Correlates of Sarcopenia in Community-Dwelling Older People: Application of the EWGSOP Definition and Diagnostic Algorithm. J Gerontol A Biol Sci Med Sci. 2014 Apr;69(4):438-46.

  4. Rolland Y, Czerwinski S, Abellan Van Kan G, Morley JE, Cesari M, Onder G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008 Aug-Sep;12(7):433-50.

  5. Cerullo F, Gambassi G, Cesari M. Rationale for Antioxidant Supplementation in Sarcopenia. J Aging Res. 2012; 2012:316943.

  6. Heaney RP, Layman DK. Amount and type of protein influences bone health. Am J Clin Nutr. 2008; 87(5):1567S-70S.

  7. Kuipers RS, Luxwolda MF, Dijck-Brouwer D, Eaton SB, Crawford MA, Cordain L, et al. Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet. Br J Nutr. 2010;104(11):1666-87.

  8. Lambert CP, Frank LL, Evans WJ. Macronutrient considerations for the sport of bodybuilding. Sports Med. 2004;34(5):317-27.

  9. Raynaud-Simon A, Revel-Delhom C, Hébuterne X. French Nutrition and Health Program, French Health High Authority. Clinical practice guidelines from the French Health High Authority: nutritional support strategy in protein-energy malnutrition in the elderly. Clin Nutr. 2011;30(3):312-9.

  10. Kelly OJ, Gilman JC, Kim Y, Ilich JZ. Longchain polyunsaturated fatty acids may mutually benefit both obesity and osteoporosis. Nutr Res. 2013;33(7):521-33.

  11. Wheeler ML, Dunbar SA, Jaacks LM, Karmally W, Mayer-Davis EJ, Wylie-Rosett J. Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature. Diabetes Care. 2012 Feb;35(2):434-45.

  12. Nowson C, O’Connell S. Protein requirements and recommendations for older people: a Review. Nutrients. 2015;7(8):6874-99.

  13. Paddon-Jones D, Rasmussen B. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care. 2009 Jan;12 (1):86-90.

  14. Leenders M, van Loon LJ. Leucine as a pharmaconutrient to prevent and treat sarcopenia and type 2 diabetes. Nutr Rev. 2011 Nov;69(11):675-89.

  15. Gregorio L, Brindisi J, Kleppinger A, Sullivan R, Mangano KM, Bihuniak JD, et al. Adequate dietary protein is associated with better physical performance among post-menopausal women 60-90 years. J Nutr Health Aging, 2014;18(2):155-60.

  16. Bourges H, Casanueva E, Rosado JL. Recomendaciones de ingestión de nutrimentos para la población mexicana. México: Editorial Médica Panamericana; 2005.

  17. Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, et al. American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis - 2016--executive summary. Endocr Pract. 2016;22(9):1111-8.

  18. Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N, et al. National Osteoporosis Guideline Group (NOGG). UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2017;12(1):43.

  19. Institute of Medicine. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (2002/2005); Dietary reference intakes for calcium and vitamin D (2011). USA: Institute of Medicine. Disponible en https://www.nap.edu/ read/10490/chapter/1 [Consultado en octubre de 2017].

  20. Organización Mundial de la Salud (OMS). Estrategia mundial sobre régimen alimentario, actividad física y salud. ¿Qué se entiende sobre actividad moderada y actividad vigorosa?. OMS. Disponible en http:// www.who.int/dietphysicalactivity/physical_activity_ intensity/es/ [Consultado en septiembre del 2017].

  21. Kelly OJ, Gilman JC. Can Unconventional Exercise be Helpful in the Treatment, Management and Prevention of Osteosarcopenic Obesity? Curr Aging Sci. 2017;10(2):106-21.

  22. Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, et al. American College of Sports Medicine. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334-59.

  23. Zaleski AL, Taylor BA, Panza GA, Wu Y, Pescatello LS, Thompson PD, et al. Coming of Age: Considerations in the Prescription of Exercise for Older Adults. Methodist Debakey Cardiovasc J. 2016;12 (2):98-104.

  24. Liao CD, Tsauo JY, Lin LF, Huang SW, Ku JW, Chou LC, et al. Effects of elastic resistance exercise on body composition and physical capacity in older women with sarcopenic obesity: A CONSORT-compliant prospective randomized controlled trial. Medicine (Baltimore). 2017;96(23): e7115.

  25. Balachandran A, Krawczyk SN, Potiaumpai M, Signorile JF. High-speed circuit training vs. hypertrophy training to improve physical function in sarcopenic obese adults: a randomized controlled trial. Exp Gerontol. 2014;60:64-71.

  26. Theodorakopoulos C, Jones J, Bannerman E, Greig CA. Effectiveness of nutritional and exercise interventions to improve body composition and muscle strength or function in sarcopenic obese older adults: A systematic review. Nutr Res. 2017;43:3-15.

  27. Naranjo JD, Dziki JL, Badylak SF. Regenerative Medicine Approaches for Age-related Muscle Loss and Sarcopenia: A Mini-Review. Gerontology. 2017; 63(6):580-9.

  28. Houry D, Florence C, Baldwin G, Stevens J, Mc- Clure R. The CDC Injury Center’s response to the growing public health problem of falls among older adults. Am J Lifestyle Med. 2016 Jan-Feb;10(1).

  29. Stopping Elderly Accidents, Deaths and Injuries (STEADI). Centers for Disease Control and Prevention. STEADI Materials for Healthcare Providers. Disponible en: https://www.cdc.gov/steadi/materials. html [Consultado en octubre de 2017].

  30. Shaw K, O’Rourke P, Del Mar C, Kenardy J. Psychological interventions for overweight or obesity. Cochrane Database Syst Rev. 2005;(2):CD003818.

  31. Shah K, Wingkun NJ, Lambert CP, Villareal DT. Weight-loss therapy improves endurance capacity in obese older adults. J Am Geriatr Soc. 2008;56 (6):1157-9.

  32. Mathus-Vliegen EM. Obesity Management Task Force of the European Association for the Study of Obesity. Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline. Obes Facts. 2012;5(3):460-83.

  33. Chan DD, Tsou HH, Chang CB, Yang RS, Tsauo JY, Chen CY, et al. Integrated care for geriatric frailty and sarcopenia: a randomized control trial. J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):78-88.

  34. Arantxa Colchero M, Caro-Vega Y, Kaufer-Horwitz M. Socioeconomic status and misperception of body mass index among Mexican adults. Salud Publica Mex. 2014;56(3):251-8.

  35. Besser SJ, Anderson JE, Weinman J. How do osteoporosis patients perceive their illness and treatment? Implications for clinical practice. Arch Osteoporos. 2012;7:115-24.



>Revistas >Revista Médica del Instituto Mexicano del Seguro Social >Año2018, No. S1
 

· Indice de Publicaciones 
· ligas de Interes 






       
Derechos Resevados 2019